Tinengotinib shows activity in FGFR-altered cholangiocarcinoma post-FGFR inhibitor therapy. Learn more about the phase 2 ...

When Cindy Mrotek and Katie Glenn became caregivers for their parents with cholangiocarcinoma, but they didn’t just find support, they found someone who understood every fear, hope and uncertainty.

Each anatomical subtype of cholangiocarcinoma, intrahepatic (iCCA), perihilar (pCCA) and distal (dCCA), has a distinct epidemiology, biology, and prognosis, thus necessitating different management ...

Gallbladder cancer and cholangiocarcinoma are different types of biliary tract cancer. They affect the same system in the body and cause similar symptoms, but they may require different treatments.

Genfit has announced encouraging preliminary results from its phase 1b clinical trial evaluating investigational drug GNS561 in combination with a MEK inhibitor (MEKi) in patients with KRAS mutated ...

Stacie C. Lindsey is being recognized for her patient advocacy, alignment of research efforts and collaboration among the cancer community. AstraZeneca and Scientific American Custom Media sponsor the ...

Gallbladder cancer and cholangiocarcinoma are both biliary cancers. They can cause the same symptoms, but causes and treatments can differ. Gallbladder cancer is cancer of the gallbladder, while ...

NANJING, China and GAITHERSBURG, Md., Dec. 4, 2025 /PRNewswire/ -- TransThera Sciences Inc. ("TransThera") announced the publication of clinical results from a US-based Phase 2 trial evaluating ...

Sydney Towle, 26, has recently been documenting her treatments in a clinical trial for her rare, aggressive bile duct cancer ...